BridgeMD
Oxytocin and attachment development: Looking beyond the expected?
EU CTIS ID: 2024-518004-49-00
What this study is testing
We will use principles deduced from the Learning Theory of Attachment (LTA) to evaluate to what extent oxytocin has attenuating effects on trust learning. To this end, we will conduct a VR experiment because it allows us to study the dynamics underlying trust learning in a realistic setting. In addition, we will conduct a task that assesses cognitive flexibility, namely the Probabilistic Reversal Learning Task (PRLT), to test whether the possible attenuating effects of oxytocin are limited to the level of social learning or also extend to a more basic level of learning.
- Phase I and Phase II (Integrated)- Other
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
- Participants must have an age that is between 9 and 13 years old
You likely can't join if
- Participant has a history of an oxytocin allergy
- Any disorder, which in the Investigator’s opinion might jeopardise the participant’s safety or compliance with the protocol
- Any prior or concomitant treatment(s) that might jeopardise the participant’s safety or that would compromise the integrity of the Trial
- Participation in an interventional Trial with an investigational medicinal product (IMP) or device
- A kidney or cardial condition
- Participant is taking any medication at the time of testing
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.